Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | AP1M2 |
| Upstream (Parents) |
|---|
| (<<) RAB25 → AP1M2 |
| (<<) PRR5-ARHGAP8///PRR5///ARHGAP8 → AP1M2 |
| Downstream (Children) |
|---|
| AP1M2 → BMP4 (>>) |
| AP1M2 → UGT8 (>>) |
| AP1M2 → RAPGEFL1 (>>) |
| AP1M2 → SMPDL3B (>>) |
| AP1M2 → SFN (>>) |
| AP1M2 → PRR5-ARHGAP8///PRR5///ARHGAP8 (>>) |
| AP1M2 → PITX1 (>>) |
| AP1M2 → OVOL1 (>>) |
| AP1M2 → MYOM2 (>>) |
| AP1M2 → TRAIP (>>) |
| AP1M2 → LRFN4 (>>) |
| AP1M2 → SF3A2 (>>) |
| AP1M2 → ASF1B (>>) |
| AP1M2 → EFCAB6 (>>) |
| AP1M2 → SH2D3A (>>) |
| AP1M2 → CXorf36 (>>) |
| AP1M2 → LPAR2 (>>) |
| AP1M2 → KATNB1 (>>) |
| AP1M2 → FGFBP1 (>>) |
| AP1M2 → MARCKSL1 (>>) |
| AP1M2 → NBEAL2 (>>) |
